Literature DB >> 1762903

Echinomycin binding to alternating AT.

K R Fox1, J N Marks, K Waterloh.   

Abstract

We have studied the binding of echinomycin to DNA fragments containing GC-rich regions flanked by blocks of alternating AT by DNase I footprinting and diethylpyrocarbonate modification. Regions of alternating AT flanking the sequences CCCG, CCGC, CGGC and GG show a four base pair DNase I cleavage pattern and reaction of alternate adenines with diethylpyrocarbonate. This pattern is strongest when the AT-block is immediately adjacent to the CpG ligand binding site. We explain these phenomena by suggesting that echinomycin binds to the dinucleotide step ApT in a cooperative fashion. The cooperative effects can be transmitted through the dinucleotide step GC but not CC or AA. No such repetitive patterns are seen with surrounding regions of (ATT).(AAT). Evidence is presented for secondary drug binding sites at CpC and TpG with weaker interaction at the CpG site within the hexanucleotide TTCGAA.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1762903      PMCID: PMC329301          DOI: 10.1093/nar/19.24.6725

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  20 in total

1.  Effect of actinomycin on a (TA)6 plasmid insert.

Authors:  K Waterloh; K R Fox
Journal:  Anticancer Drug Des       Date:  1990-02

2.  The GC-selective ligand mithramycin alters the structure of (AT)n sequences flanking its binding sites.

Authors:  B M Cons; K R Fox
Journal:  FEBS Lett       Date:  1990-05-07       Impact factor: 4.124

3.  Sequence preferences in the binding to DNA of triostin A and TANDEM as reported by DNase I footprinting.

Authors:  C M Low; R K Olsen; M J Waring
Journal:  FEBS Lett       Date:  1984-10-29       Impact factor: 4.124

4.  A comparison of the structure of echinomycin and triostin A complexed to a DNA fragment.

Authors:  G Ughetto; A H Wang; G J Quigley; G A van der Marel; J H van Boom; A Rich
Journal:  Nucleic Acids Res       Date:  1985-04-11       Impact factor: 16.971

5.  DNA sequence recognition by under-methylated analogues of triostin A.

Authors:  C M Low; K R Fox; R K Olsen; M J Waring
Journal:  Nucleic Acids Res       Date:  1986-03-11       Impact factor: 16.971

6.  The effects of actinomycin on the structure of dAn.dTn and (dA-dT)n regions surrounding its GC binding site. A footprinting study.

Authors:  K Waterloh; K R Fox
Journal:  J Biol Chem       Date:  1991-04-05       Impact factor: 5.157

7.  Association of actinomycin D and deoxyribodinucleotides as a model for binding of the drug to DNA.

Authors:  T R Krugh
Journal:  Proc Natl Acad Sci U S A       Date:  1972-07       Impact factor: 11.205

8.  Echinomycin binding to the sequence CG(AT)nCG alters the structure of the central AT region.

Authors:  K R Fox; E Kentebe
Journal:  Nucleic Acids Res       Date:  1990-04-25       Impact factor: 16.971

9.  Diethyl pyrocarbonate can detect a modified DNA structure induced by the binding of quinoxaline antibiotics.

Authors:  J Portugal; K R Fox; M J McLean; J L Richenberg; M J Waring
Journal:  Nucleic Acids Res       Date:  1988-05-11       Impact factor: 16.971

10.  Footprinting studies on the effect of echinomycin on the structure of a bent DNA fragment.

Authors:  K R Fox; E Kentebe
Journal:  Biochem J       Date:  1990-07-01       Impact factor: 3.857

View more
  3 in total

1.  The 2-amino group of guanine is absolutely required for specific binding of the anti-cancer antibiotic echinomycin to DNA.

Authors:  C Marchand; C Bailly; M J McLean; S E Moroney; M J Waring
Journal:  Nucleic Acids Res       Date:  1992-11-11       Impact factor: 16.971

2.  Localized chemical reactivity in DNA associated with the sequence-specific bisintercalation of echinomycin.

Authors:  C Bailly; D Gentle; F Hamy; M Purcell; M J Waring
Journal:  Biochem J       Date:  1994-05-15       Impact factor: 3.857

3.  Dissociation of the AT-specific bifunctional intercalator [N-MeCys3,N-MeCys7]TANDEM from TpA sites in DNA.

Authors:  M C Fletcher; R K Olsen; K R Fox
Journal:  Biochem J       Date:  1995-02-15       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.